MINNEAPOLIS (November 16, 2017) – Last night, OneOme was awarded a Tekne Award in Healthcare at the 18th Annual Minnesota High Tech Association (MHTA) Tekne Awards. The Tekne Awards honor companies and individuals in Minnesota who have demonstrated superior technology innovation and leadership. OneOme’s RightMed® pharmacogenomic solution leads the way in personalized medicine by identifying how a patient's DNA and current medications may affect their response to medications.
“OneOme is honored by this prestigious recognition,” Paul Owen, CEO of OneOme, said. “Every day, our team is pushing to make the life-saving science of pharmacogenomics available and accessible to everyone. Thank you to the MHTA for recognizing OneOme’s leadership in precision medicine and healthcare technology.”
OneOme is backed by early-stage venture firm Invenshure, a Minnesota-based healthcare incubator, and Mayo Clinic. OneOme’s RightMed comprehensive test, co-developed by Mayo Clinic, has the potential to address the crisis of adverse drug reactions and drug ineffectiveness by analyzing how a person’s genes may predict their response to medications. OneOme’s pharmacogenomic testing and clinical support tools are easy-to-use, intuitive and ready to be integrated into clinical practices. The RightMed comprehensive test covers hundreds of medications for a wide range of medical conditions, including psychiatric conditions, cancer, chronic pain, cardiovascular disease, and more. It also can be integrated into electronic medical records (EMRs).
To date, over 450 locations from more than 22 different countries have ordered OneOme’s RightMed test. OneOme continues to build research and commercial partnerships across the globe, including recent partnerships in Canada, Australia, Mexico, Japan, Hong Kong, and Macau.
Presented by the MHTA, the Tekne Awards annually recognize Minnesota’s best and brightest technology users and developers in innovation, development, education, commercialization, and management. More information is available at tekneawards.org.
About Minnesota High Tech Association (MHTA)
MHTA is an innovation and technology association united in fueling Minnesota’s prosperity. We help bring together the people of Minnesota’s technology ecosystem and lead the charge in directing technology issues to Minnesota’s state capitol. MHTA is the only membership organization that represents Minnesota’s entire technology-based economy. MHTA members include organizations of every size − involved in virtually every aspect of technology creation, production, application and education in Minnesota. Find out more online at http://www.mhta.org or follow MHTA on Twitter at http://twitter.com/MHTA.
The OneOme platform was co-developed and exclusively licensed from Mayo Clinic to bring pharmacogenomics into routine clinical care. OneOme is a privately held company backed by early-stage venture firm Invenshure, LLC, and Mayo Clinic. To learn more about OneOme, visit oneome.com.
Editor’s Note: Mayo Clinic has financial investment in the technology referenced in this news release. The revenue that Mayo Clinic will receive is used to support its not-for-profit mission in patient care, education and research.